Supraspinatus tendinopathy. Shoulder lesion, unspecified
Conditions
Interventions
Intervention 1: Intervention group: One injection of 30 units of Dysport into the supraspinatus muscle and 40 mg of methylprednisolone into the bursa of the supraspinatus tendon sheath once. Intervent
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients with supraspinatus tendinopathy Confirmation of the problem by examination and ultrasound Not having previously received treatment Intervention should be carried out as a first line Age between 20-70 years
Exclusion criteria
Exclusion criteria: History of trauma to the hand and shoulder area in the last 6 months History of humerus fracture Complete rupture of the supraspinatus tendon Acromioclavicular joint osteoarthritis Calcific tendonitis Pregnancy and breastfeeding Presence of nerve damage or neurological disorders that cause upper limb dysfunction The existence of psychological problems History of shoulder surgery Patient's lack of cooperation in assessing range of motion History of corticosteroid injection into the shoulder within the past 6 months Concomitant radiculopathy Coincidence with frozen shoulder Systemic inflammatory diseases History of sensitivity to botulonium toxin History of sensitivity to corticosteroid
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shoulder range of motion. Timepoint: Before injection,1and 3 months later. Method of measurement: Physical exam and questioner.;Shoulder pain. Timepoint: Before injection,1and 3 months later. Method of measurement: Questioner. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before injection,1and 3months later. Method of measurement: Questioner. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Mansoor raygani
Shahid Beheshti University of Medical Sciences
Outcome results
None listed